• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脓毒症患者体内内毒素受体(CD14)的调节

Modulation of the endotoxin receptor (CD14) in septic patients.

作者信息

Birkenmaier C, Hong Y S, Horn J K

机构信息

Department of Surgery, San Francisco General Hospital, University of California 64143-0807.

出版信息

J Trauma. 1992 Apr;32(4):473-8; discussion 478-9.

PMID:1373777
Abstract

The monocyte is a pivotal cell in septic patients that responds to endotoxin with release of inflammatory cytokines. Monocytes display on their surface a receptor (CD14) for complexes formed by endotoxin (lipopolysaccharide, LPS) and a plasma LPS-binding protein (LBP). We compared monocytes obtained from normal controls with those obtained from septic patients for expression of CD14 by flow cytometric analysis of immunofluorescent-stained cells. In normal individuals and patients, 75%-95% of monocytes are CD14 positive (CD14+). Mean fluorescence exhibited by the CD14+ population was measured after maintaining cells at 37 degrees C for 15 minutes and compared with baseline cells held at 4 degrees C (mean fluorescence ratio). All cells increased their CD14 mean fluorescence ratio with warming; however, the level achieved by monocytes obtained from septic patients was on average 78% +/- 8% of control levels (p = 0.014). To further clarify CD14 expression, we examined the effect of Escherichia coli LPS on normal monocytes by comparing monocytes treated in serum-free buffer (no LBP) with monocytes treated in whole blood (containing LBP). The LPS (1.0 ng/mL) incubated with whole blood for 120 minutes generated an increase in CD14+ mean fluorescence compared with buffer. In contrast, phorbol myristate acetate lowered CD14+ mean fluorescence levels. These data indicate that normal monocytes incubated in the presence of ligand (LBP-LPS complexes) increase their expression of CD14, whereas CD14 expression in septic patients is diminished. We conclude that monocytes from septic patients were responsive to other stimuli aside from LPS and that decreased expression of CD14 may indicate a poor prognosis.

摘要

单核细胞是脓毒症患者体内的关键细胞,可通过释放炎性细胞因子对内毒素作出反应。单核细胞表面存在一种受体(CD14),可识别由内毒素(脂多糖,LPS)与血浆LPS结合蛋白(LBP)形成的复合物。我们通过对免疫荧光染色细胞进行流式细胞术分析,比较了正常对照者与脓毒症患者的单核细胞中CD14的表达情况。在正常个体和患者中,75%-95%的单核细胞为CD14阳性(CD14+)。将细胞在37℃孵育15分钟后,测量CD14+群体的平均荧光强度,并与保存在4℃的基线细胞进行比较(平均荧光比率)。所有细胞在升温后其CD14平均荧光比率均升高;然而,脓毒症患者的单核细胞达到的水平平均为对照水平的78%±8%(p = 0.014)。为进一步阐明CD14的表达情况,我们通过比较无血清缓冲液(不含LBP)处理的单核细胞与全血(含LBP)处理的单核细胞,研究了大肠杆菌LPS对正常单核细胞的影响。与缓冲液相比,LPS(1.0 ng/mL)与全血孵育120分钟后,CD14+平均荧光强度增加。相反,佛波酯肉豆蔻酸酯降低了CD14+平均荧光水平。这些数据表明,在配体(LBP-LPS复合物)存在的情况下孵育的正常单核细胞会增加其CD14的表达,而脓毒症患者的CD14表达则降低。我们得出结论,脓毒症患者的单核细胞除了对LPS有反应外,还对其他刺激有反应,CD14表达降低可能预示预后不良。

相似文献

1
Modulation of the endotoxin receptor (CD14) in septic patients.脓毒症患者体内内毒素受体(CD14)的调节
J Trauma. 1992 Apr;32(4):473-8; discussion 478-9.
2
Cross-linking of lipopolysaccharide (LPS) to CD14 on THP-1 cells mediated by LPS-binding protein.脂多糖结合蛋白介导脂多糖(LPS)与THP-1细胞上的CD14交联。
J Immunol. 1993 Apr 1;150(7):3011-21.
3
Transforming growth factor-beta 1 lowers the CD14 content of monocytes.
J Surg Res. 1994 Nov;57(5):574-8. doi: 10.1006/jsre.1994.1185.
4
Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes.人外周血单核细胞中脂多糖(LPS)结合及LPS诱导的肿瘤坏死因子分泌的调控
J Immunol. 1992 Jun 1;148(11):3505-12.
5
Expression and release of the monocyte lipopolysaccharide receptor antigen CD14 are suppressed by glucocorticoids in vivo and in vitro.单核细胞脂多糖受体抗原CD14的表达及释放,在体内和体外均受到糖皮质激素的抑制。
J Immunol. 1997 Feb 1;158(3):1345-52.
6
Mechanisms of cytokine cascade activation in patients with sepsis: normal cytokine transcription despite reduced CD14 receptor expression.脓毒症患者细胞因子级联激活的机制:尽管CD14受体表达降低,但细胞因子转录正常。
Surgery. 1993 Aug;114(2):243-50; discussion 250-1.
7
Effect of cytokines and lipopolysaccharide on CD14 antigen expression in human monocytes and macrophages.细胞因子和脂多糖对人单核细胞和巨噬细胞中CD14抗原表达的影响。
J Cell Biochem. 1991 Dec;47(4):317-29. doi: 10.1002/jcb.240470406.
8
Immunodepressive effects of LPS on monocyte CD14 in vivo.脂多糖(LPS)在体内对单核细胞CD14的免疫抑制作用。
J Surg Res. 1997 Apr;69(1):7-10. doi: 10.1006/jsre.1997.5010.
9
sCD14 prevents endotoxin inducible oxidative burst response of human monocytes.
Allerg Immunol (Leipz). 1991;37(3-4):159-64.
10
Endotoxin-neutralizing capacity of soluble CD14 is a highly conserved specific function.可溶性CD14的内毒素中和能力是一种高度保守的特定功能。
Circ Shock. 1993 Mar;39(3):220-5.

引用本文的文献

1
Oxidant alterations in CD16 expression are cytoskeletal induced.CD16 表达的氧化剂改变是由细胞骨架诱导的。
Shock. 2009 Dec;32(6):572-7. doi: 10.1097/SHK.0b013e3181a72530.
2
Flow cytometric measurement of HLA-DR expression on circulating monocytes in healthy and sick neonates using monocyte negative selection.采用单核细胞阴性选择法,通过流式细胞术检测健康和患病新生儿循环单核细胞上HLA-DR的表达。
Clin Exp Immunol. 2001 Mar;123(3):402-7. doi: 10.1046/j.1365-2249.2001.01471.x.
3
Increased levels of circulating soluble CD14 in Kawasaki disease.
川崎病中循环可溶性CD14水平升高。
Clin Exp Immunol. 2000 Feb;119(2):376-81. doi: 10.1046/j.1365-2249.2000.01120.x.
4
Endotoxin binding and elimination by monocytes: secretion of soluble CD14 represents an inducible mechanism counteracting reduced expression of membrane CD14 in patients with sepsis and in a patient with paroxysmal nocturnal hemoglobinuria.单核细胞对内毒素的结合与清除:可溶性CD14的分泌代表一种可诱导机制,可抵消脓毒症患者和阵发性夜间血红蛋白尿患者膜CD14表达的降低。
Infect Immun. 1998 Mar;66(3):1135-41. doi: 10.1128/IAI.66.3.1135-1141.1998.
5
CD14 expression in injured patients correlates with outcome.受伤患者体内的CD14表达与预后相关。
Ann Surg. 1996 Jul;224(1):91-6. doi: 10.1097/00000658-199607000-00014.
6
Detection of cytoplasmic IL-1 beta in peripheral blood mononuclear cells from intensive care unit (ICU) patients.检测重症监护病房(ICU)患者外周血单个核细胞中的细胞质白细胞介素-1β
Clin Exp Immunol. 1995 May;100(2):330-5. doi: 10.1111/j.1365-2249.1995.tb03673.x.